AMYLIN PHARMACEUTICALS INC Revenue
AMYLIN PHARMACEUTICALS INC reported Revenue of $169.33 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC revenues for the quarter ending 2012-06-30 was $169.33M, a 7.12% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC revenues for the quarter ending 2012-03-31 was $153.69M, a 0.64% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC revenues for the quarter ending 2011-12-31 was $164.94M, a 5.31% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC revenues for the quarter ending 2011-09-30 was $174.96M, a 12.08% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC revenues for fiscal 2011 was $650.68M, a 2.71% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC revenues for fiscal 2010 was $668.81M, a 11.81% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC revenues for fiscal 2009 was $758.42M, a 1.46% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC revenues for fiscal 2008 was $769.63M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2012-06-30 | $169.33M 10-Q · filed 2012-08-03 | $323.01M 10-Q · filed 2012-08-03 | $487.95M derived: sum of 3 quarters · filed 2012-08-03 | $662.91M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $153.69M 10-Q · filed 2012-05-07 | $318.62M derived: sum of 2 quarters · filed 2012-05-07 | $493.58M derived: sum of 3 quarters · filed 2012-05-07 | $651.65M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $164.94M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $339.90M derived: sum of 2 quarters · filed 2012-02-22 | $497.96M derived: sum of 3 quarters · filed 2012-08-03 | $650.68M 10-K · filed 2012-02-22 |
| 2011-09-30 | $174.96M 10-Q · filed 2011-10-28 | $333.03M derived: sum of 2 quarters · filed 2012-08-03 | $485.74M 10-Q · filed 2011-10-28 | $659.93M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $158.06M 10-Q · filed 2012-08-03 | $310.78M 10-Q · filed 2012-08-03 | $484.97M derived: sum of 3 quarters · filed 2012-08-03 | $641.07M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $152.71M 10-Q · filed 2012-05-07 | $326.90M derived: sum of 2 quarters · filed 2012-05-07 | $483.00M derived: sum of 3 quarters · filed 2012-05-07 | $647.39M derived: sum of 4 quarters · filed 2012-05-07 |
| 2010-12-31 | $174.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $330.29M derived: sum of 2 quarters · filed 2012-02-22 | $494.68M derived: sum of 3 quarters · filed 2012-02-22 | $668.81M 10-K · filed 2012-02-22 |
| 2010-09-30 | $156.10M 10-Q · filed 2011-10-28 | $320.49M derived: sum of 2 quarters · filed 2011-10-28 | $494.62M 10-Q · filed 2011-10-28 | $680.15M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $164.39M 10-Q · filed 2011-08-08 | $338.52M 10-Q · filed 2011-08-08 | $524.05M derived: sum of 3 quarters · filed 2012-02-22 | $717.97M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $174.14M 10-Q · filed 2011-05-05 | $359.66M derived: sum of 2 quarters · filed 2012-02-22 | $553.58M derived: sum of 3 quarters · filed 2012-02-22 | $752.15M derived: sum of 4 quarters · filed 2012-02-22 |
| 2009-12-31 | $185.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $379.45M derived: sum of 2 quarters · filed 2012-02-22 | $578.02M derived: sum of 3 quarters · filed 2012-02-22 | $758.42M 10-K · filed 2012-02-22 |
| 2009-09-30 | $193.92M 10-Q · filed 2010-11-08 | $392.49M derived: sum of 2 quarters · filed 2010-11-08 | $572.89M 10-Q · filed 2010-11-08 | |
| 2009-06-30 | $198.57M 10-Q · filed 2010-08-05 | $378.97M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $769.63M 10-K · filed 2011-02-25 |